87 related articles for article (PubMed ID: 9793616)
1. [The validity of radioimmunologic determination of bioavailability of beta-escin in horse chestnut extracts].
Schrödter A; Loew D; Schwankl W; Rietbrock N
Arzneimittelforschung; 1998 Sep; 48(9):905-10. PubMed ID: 9793616
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of escin after administration of two oral formulations containing aesculus extract.
Kunz K; Lorkowski G; Petersen G; Samcova E; Schaffler K; Wauschkuhn CH
Arzneimittelforschung; 1998 Aug; 48(8):822-5. PubMed ID: 9748710
[TBL] [Abstract][Full Text] [Related]
3. Measurement of the bioavailability of aescin-containing extracts.
Loew D; Schrödter A; Schwankl W; März RW
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):537-42. PubMed ID: 11196340
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the bioavailability of beta-aescin after single oral administration of two different drug formulations containing an extract of horse-chestnut seeds].
Schrader E; Schwankl W; Sieder C; Christoffel V
Pharmazie; 1995 Sep; 50(9):623-7. PubMed ID: 7480102
[TBL] [Abstract][Full Text] [Related]
5. [Pharmaokinetics of beta-escin after administration of various Aesculus extract containing formulations].
Oschmann R; Biber A; Lang F; Stumpf H; Kunz K
Pharmazie; 1996 Aug; 51(8):577-81. PubMed ID: 8975251
[TBL] [Abstract][Full Text] [Related]
6. [Conservative therapy of chronic venous insufficiency. The extent of the edema-preventive effect of horse chestnut seed extract].
Steiner M
Vasa Suppl; 1991; 33():217. PubMed ID: 1788677
[No Abstract] [Full Text] [Related]
7. Bioavailability of beta-aescin from horse chestnut seed extract: comparative clinical studies of two Galenic formulations.
Bässler D; Okpanyi S; Schrödter A; Loew D; Schürer M; Schulz HU
Adv Ther; 2003; 20(5):295-304. PubMed ID: 14964349
[TBL] [Abstract][Full Text] [Related]
8. [Bioavailability of beta-aescin after oral administration of two preparations containing aesculus extract to healthy volunteers].
Kunz K; Schaffler K; Biber A; Wauschkuhn CH
Pharmazie; 1991 Feb; 46(2):145. PubMed ID: 1852768
[No Abstract] [Full Text] [Related]
9. Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat.
Wu XJ; Zhang ML; Cui XY; Gao F; He Q; Li XJ; Zhang JW; Fawcett JP; Gu JK
J Ethnopharmacol; 2012 Jan; 139(1):201-6. PubMed ID: 22094055
[TBL] [Abstract][Full Text] [Related]
10. [The therapeutic effectiveness of chestnut extract].
Hitzenberger G
Wien Med Wochenschr; 1989 Sep; 139(17):385-9. PubMed ID: 2686181
[TBL] [Abstract][Full Text] [Related]
11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal].
Dittgen M; Zimmermann H; Wober W; Höflich C; Breitbarth H; Timpe C
Pharmazie; 1996 Aug; 51(8):608-10. PubMed ID: 8975254
[No Abstract] [Full Text] [Related]
13. Beta-escin, a natural triterpenoid saponin from Chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis.
Niu YP; Wu LM; Jiang YL; Wang WX; Li LD
J Pharm Pharmacol; 2008 Sep; 60(9):1213-20. PubMed ID: 18718126
[TBL] [Abstract][Full Text] [Related]
14. Medical edema protection--clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study.
Diehm C; Vollbrecht D; Amendt K; Comberg HU
Vasa; 1992; 21(2):188-92. PubMed ID: 1621440
[TBL] [Abstract][Full Text] [Related]
15. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers.
Sterk V; Büchele B; Simmet T
Planta Med; 2004 Dec; 70(12):1155-60. PubMed ID: 15643550
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
17. [Comparative pharmacokinetics of 800 mg of acyclovir-containing Telviran and Zovirax tablets in healthy volunteers].
Baloghné NK; Grézal G; Dalmadiné KB; Tömló J; Patai V; Nagy L; Mózsik G; Csörgó M; Szentpéteri I; Klebovich I
Acta Pharm Hung; 1999 Jan; 69(1):36-45. PubMed ID: 10513411
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography.
Scalia S; Scagliarini R; Pazzi P
Arzneimittelforschung; 2000 Feb; 50(2):129-34. PubMed ID: 10719615
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts.
Kapusta I; Janda B; Szajwaj B; Stochmal A; Piacente S; Pizza C; Franceschi F; Franz C; Oleszek W
J Agric Food Chem; 2007 Oct; 55(21):8485-90. PubMed ID: 17867637
[TBL] [Abstract][Full Text] [Related]
20. [Horse chestnut seed extract--an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency].
Greeske K; Pohlmann BK
Fortschr Med; 1996 May; 114(15):196-200. PubMed ID: 8767939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
